In accord with a context-dependent role of EZH2 as a tumor suppressor or an oncogene, targeted disruption of EZH2 by shRNA or EZH2 inhibitory drugs strongly suppressed the proliferation of other models of pediatric brain tumors. Here, EZH2 is linked to neoplasm.